Samuel H. Gellman, William L. Murphy, Katrina T. Forest, and coworkers have designed a two-helix α/β-peptide with afffinity for VEGF and demonstrated its use by inhibiting the growth of cells lining blood vessels, a process important in limiting the growth of cancerous tissue. Using the same method, the researchers created two modified versions that also selectively bind the large proteins TNF-α and IgG Read Full Article